Alector, Inc.
NASDAQ:ALECBiotechnology
Healthcare
$2.57 +5.13%
+$0.08 today
- Market cap
- $382.61M
- Beta
- 0.59
- P/E (TTM)
- -1.4
- EPS (TTM)
- -$1.13
52W Low $1.09High $3.40
Volume 2.13M
Average 0.65M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$184.03M
FY 2025 · Annual
Investing Cash Flow
$196.60M
FY 2025 · Annual
+83.5% YoYFinancing Cash Flow
$20.21M
FY 2025 · Annual
-75.2% YoYCash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (36.33M) | (133.31M) | (130.39M) | (119.05M) | (142.93M) |
| Depreciation & Amortization | 8.32M | 8.47M | 8.85M | 8.84M | (861K) |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 40.79M | 46.15M | 42.8M | 39.46M | 26.66M |
| Change in Working Capital | 283.68M | 59.53M | (90.15M) | (146.99M) | (74.06M) |
| Accounts Receivables | (7.39M) | 4.8M | 2.59M | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 1.92M | (572K) | (377K) | (1.44M) | (524K) |
| Other Working Capital | 289.16M | 55.29M | (92.36M) | (145.55M) | (73.53M) |
| Other Non-Cash Items | 2.1M | (1.16M) | (15.27M) | (12.17M) | 7.16M |
| Operating Cash Flow | 298.55M | (20.33M) | (184.16M) | (229.91M) | (184.03M) |
| Capital Expenditures | (3.25M) | (4.12M) | (2.38M) | (1.26M) | (41K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (343.4M) | (556.9M) | (551.73M) | (467.74M) | (271.88M) |
| Sales of Investments | 296.99M | 402M | 656.03M | 576.13M | 468.52M |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (49.66M) | (159.01M) | 101.92M | 107.13M | 196.6M |
| Debt Repayment | 0 | 0 | 0 | 9.39M | 0 |
| Common Stock Issued | 0 | 4.51M | 2.55M | 71.11M | 20M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 30.3M | 0 | 0 | 1.04M | 217K |
| Financing Cash Flow | 30.3M | 4.51M | 2.55M | 81.54M | 20.22M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 279.18M | (174.83M) | (79.69M) | (41.23M) | 32.78M |
| Free Cash Flow | 295.3M | (24.45M) | (186.54M) | (231.16M) | (184.07M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$142.9M
+ D&A-$861.0K
+ Stock-Based Comp$26.7M
+ Deferred Tax$0
- Working Capital-$74.1M
+ Other Non-Cash$7.2M
= Operating Cash Flow-$184.0M
- Capex-$41.0K
= Free Cash Flow-$184.1M
Analysis
FY2025 free cash flow is -$184.1M. FCF conversion is 128.8% of net income. Operating cash flow was -$184.0M, with capex of -$41.0K. The largest bridge item is Working Capital at -$74.1M.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 5, 2026 | |
| 10-Q | Quarterly report | Nov 5, 2026 | |
| SC 13G | SC 13G filing | Oct 26, 2026 | |
| SC 13G | SC 13G filing | Oct 23, 2026 | |
| 8-K | Current report | Oct 16, 2026 |
Does ALEC generate free cash flow?
Alector, Inc. (ALEC) generated -$184.07M of free cash flow in fiscal 2025.
How much operating cash flow does ALEC produce?
Operating cash flow was -$184.03M, before capital expenditures of $41,000.00.
Continue the stock analysis
Jump to another research area for this company.